{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T01:30:16Z","timestamp":1774661416725,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000},"content-version":"vor","delay-in-days":6460,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1378\/chest.113.5.1201","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T22:31:17Z","timestamp":1201041077000},"page":"1201-1206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Implications for Macrolide Treatment in Community-Acquired Pneumonia"],"prefix":"10.1016","volume":"113","author":[{"given":"Linda M.","family":"Mundy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Oldach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G","family":"Auwaerter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Gaydos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.113.5.1201_bib1","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199512143332408","article-title":"Community-acquired pneumonia","volume":"333","author":"Bartlett","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.113.5.1201_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/clinids\/18.4.501","article-title":"Community-acquired pneumonia","volume":"18","author":"Marrie","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.113.5.1201_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005792-199009000-00004","article-title":"New and emerging etiologies for community-acquired pneumonia with implications for therapy; a prospective multicenter study of 359 cases","volume":"69","author":"Fang","year":"1990","journal-title":"Medicine"},{"key":"10.1378\/chest.113.5.1201_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF02013650","article-title":"Etiology of community-acquired pneumonia in patients requiring hospitalization","volume":"4","author":"Berntsson","year":"1985","journal-title":"Eur J Clin Microbiol"},{"key":"10.1378\/chest.113.5.1201_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(82)90334-8","article-title":"Hospital study of adult community-acquired pneumonia","volume":"2","author":"Macfarlane","year":"1982","journal-title":"Lancet"},{"key":"10.1378\/chest.113.5.1201_bib6","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.1994.00420210049006","article-title":"Surveillance for Legionnaires' disease risk factors for morbidity and mortality","volume":"154","author":"Marston","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.113.5.1201_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00005792-198005000-00002","article-title":"Legionnaires' disease: report of 65 nosocomially acquired cases and review of the literature","volume":"59","author":"Kirby","year":"1980","journal-title":"Medicine"},{"key":"10.1378\/chest.113.5.1201_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF01647732","article-title":"Prevalence of legionellosis among adults: a study of community-acquired pneumonia in France","volume":"15","author":"Aubertin","year":"1987","journal-title":"Infection"},{"key":"10.1378\/chest.113.5.1201_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0196-6553(83)90117-7","article-title":"Community-acquired bacterial pneumonia requiring admission to hospital","volume":"11","author":"Klimek","year":"1983","journal-title":"Am J Infect Control"},{"key":"10.1378\/chest.113.5.1201_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-94-2-164","article-title":"Sporadic legionellosis in the United States: the first thousand cases","volume":"94","author":"England","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.113.5.1201_bib11","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm\/148.5.1418","article-title":"Guidelines for the initial management of adults with, community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy","volume":"148","author":"Niederman","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.113.5.1201_bib12","first-page":"346","article-title":"Guidelines for the management of community-acquired pneumonia in adults admitted to hospital","volume":"49","year":"1993","journal-title":"Br J Hosp Med"},{"key":"10.1378\/chest.113.5.1201_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0954-6111(96)80011-4","article-title":"Audit of the use of erythromycin in the treatment of community-acquired lower respiratory infections","volume":"86","author":"Jolley","year":"1992","journal-title":"Respir Med"},{"key":"10.1378\/chest.113.5.1201_bib14","first-page":"872","year":"1992"},{"key":"10.1378\/chest.113.5.1201_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/BF01975846","article-title":"Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia","volume":"10","author":"Kinasewitz","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1378\/chest.113.5.1201_bib16","first-page":"570","article-title":"Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia","volume":"14","author":"Casali","year":"1992","journal-title":"Clin Ther"},{"issue":"suppl E","key":"10.1378\/chest.113.5.1201_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/26.suppl_E.71","article-title":"Efficacy and tolerance of Cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia","volume":"26","author":"Zuck","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"pt 1","key":"10.1378\/chest.113.5.1201_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1164\/ajrccm.152.4.7551362","article-title":"Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster?","volume":"152","author":"Fein","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"pt 1","key":"10.1378\/chest.113.5.1201_bib19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1164\/ajrccm.152.4.7551387","article-title":"Community-acquired pneumonia: impact of immune status","volume":"152","author":"Mundy","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.113.5.1201_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/clinids\/19.1.157","article-title":"Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay","volume":"19","author":"Gaydos","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.113.5.1201_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/jcm.30.4.796-800.1992","article-title":"Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene","volume":"30","author":"Gaydos","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.113.5.1201_bib22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/clinids\/17.4.718","article-title":"Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population","volume":"17","author":"Gaydos","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.113.5.1201_bib23","article-title":"Methods in mycoplasmology","author":"Ravin","year":"1983"},{"key":"10.1378\/chest.113.5.1201_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00006454-199506000-00002","article-title":"Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs erythromycin ethylsuccinate","volume":"14","author":"Block","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1378\/chest.113.5.1201_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1378\/chest.104.1.208","article-title":"A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island: evidence of serologic cross-reactivity","volume":"104","author":"Kern","year":"1993","journal-title":"Chest"},{"key":"10.1378\/chest.113.5.1201_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/infdis\/163.4.757","article-title":"Infection with Chlamydia pneumoniae in Brooklyn","volume":"163","author":"Chirgwin","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1378\/chest.113.5.1201_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/jcm.10.2.259-261.1979","article-title":"Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test","volume":"10","author":"Wang","year":"1979","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.113.5.1201_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/clinids\/14.1.178","article-title":"Persistent infection with Chlamydia pneumoniae following acute respiratory illness","volume":"14","author":"Hammerschlag","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.113.5.1201_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0002-9343(90)90212-V","article-title":"Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections","volume":"89","author":"Lipsky","year":"1990","journal-title":"Am J Med"},{"key":"10.1378\/chest.113.5.1201_bib30","series-title":"Statistical methods for rates and proportions","first-page":"24","article-title":"Statistical methods for rates and proportions","author":"Fleiss","year":"1981"},{"key":"10.1378\/chest.113.5.1201_bib31","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/jcm.29.9.2082-2083.1991","article-title":"Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR","volume":"29","author":"Hyman","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.113.5.1201_bib32","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/clinids\/17.Supplement_1.S83","article-title":"Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction","volume":"17","author":"de Barbeyrac","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.113.5.1201_bib33","article-title":"A simplified protocol for the detection by PCR of Mycoplasma pneumoniae [abstract]","author":"Niesters","year":"1994","journal-title":"34th Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"10.1378\/chest.113.5.1201_bib34","article-title":"Diagnosis of Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumophila lower respiratory tract infections using polymerase chain reaction on a single throat swab specimen [abstract]","author":"Ramirez","year":"1994","journal-title":"34th Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"10.1378\/chest.113.5.1201_bib35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/jcm.32.4.903-905.1994","article-title":"Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients","volume":"32","author":"Gaydos","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.113.5.1201_bib36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/clinids\/20.5.1174","article-title":"Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture","volume":"20","author":"Hyman","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.113.5.1201_bib37","article-title":"Role of infection with Chlamydia pneumoniae among children with community-acquired pneumonia in the USA [abstract]","author":"Hammerschlag","year":"1993","journal-title":"33rd Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"10.1378\/chest.113.5.1201_bib38","article-title":"Microbiologic efficacy of azithromycin for the treatment of community-acquired lower respiratory tract infections due to Chlamydia pneumoniae [abstract]","author":"Hammerschlag","year":"1997","journal-title":"Second International Conference of Macrolides, Azalides and Streptogramins"},{"key":"10.1378\/chest.113.5.1201_bib39","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/AAC.38.9.1873","article-title":"Minireview: antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.","volume":"38","author":"Hammerschlag","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.113.5.1201_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jama.1997.03550010046038","article-title":"Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia","volume":"278","author":"Gleason","year":"1997","journal-title":"JAMA"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215475269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215475269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:39:15Z","timestamp":1698734355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215475269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["S0012369215475269"],"URL":"https:\/\/doi.org\/10.1378\/chest.113.5.1201","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1998,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications for Macrolide Treatment in Community-Acquired Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.113.5.1201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}